These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37950616)

  • 1. Travels with tau prions.
    Diamond MI
    Cytoskeleton (Hoboken); 2024 Jan; 81(1):83-88. PubMed ID: 37950616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau strains shape disease.
    Vaquer-Alicea J; Diamond MI; Joachimiak LA
    Acta Neuropathol; 2021 Jul; 142(1):57-71. PubMed ID: 33830330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau monomer encodes strains.
    Sharma AM; Thomas TL; Woodard DR; Kashmer OM; Diamond MI
    Elife; 2018 Dec; 7():. PubMed ID: 30526844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
    Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
    J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prion-Like Behavior of Assembled Tau in Transgenic Mice.
    Clavaguera F; Tolnay M; Goedert M
    Cold Spring Harb Perspect Med; 2017 Oct; 7(10):. PubMed ID: 27940600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target.
    Holmes BB; Diamond MI
    J Biol Chem; 2014 Jul; 289(29):19855-61. PubMed ID: 24860099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion-like Spreading in Tauopathies.
    Ayers JI; Giasson BI; Borchelt DR
    Biol Psychiatry; 2018 Feb; 83(4):337-346. PubMed ID: 28506438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.
    Kaufman SK; Sanders DW; Thomas TL; Ruchinskas AJ; Vaquer-Alicea J; Sharma AM; Miller TM; Diamond MI
    Neuron; 2016 Nov; 92(4):796-812. PubMed ID: 27974162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation.
    Hasegawa M
    Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau Prion-Like Propagation: State of the Art and Current Challenges.
    Dujardin S; Hyman BT
    Adv Exp Med Biol; 2019; 1184():305-325. PubMed ID: 32096046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformation determines the seeding potencies of native and recombinant Tau aggregates.
    Falcon B; Cavallini A; Angers R; Glover S; Murray TK; Barnham L; Jackson S; O'Neill MJ; Isaacs AM; Hutton ML; Szekeres PG; Goedert M; Bose S
    J Biol Chem; 2015 Jan; 290(2):1049-65. PubMed ID: 25406315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties.
    Matsumoto SE; Motoi Y; Ishiguro K; Tabira T; Kametani F; Hasegawa M; Hattori N
    Hum Mol Genet; 2015 Nov; 24(22):6403-16. PubMed ID: 26374846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and pathological heterogeneity of primary tauopathies.
    Chung DC; Roemer S; Petrucelli L; Dickson DW
    Mol Neurodegener; 2021 Aug; 16(1):57. PubMed ID: 34425874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion-like strain effects in tauopathies.
    Han ZZ; Kang SG; Arce L; Westaway D
    Cell Tissue Res; 2023 Apr; 392(1):179-199. PubMed ID: 35460367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct tau prion strains propagate in cells and mice and define different tauopathies.
    Sanders DW; Kaufman SK; DeVos SL; Sharma AM; Mirbaha H; Li A; Barker SJ; Foley AC; Thorpe JR; Serpell LC; Miller TM; Grinberg LT; Seeley WW; Diamond MI
    Neuron; 2014 Jun; 82(6):1271-88. PubMed ID: 24857020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invited review: Prion-like transmission and spreading of tau pathology.
    Clavaguera F; Hench J; Goedert M; Tolnay M
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):47-58. PubMed ID: 25399729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
    Lewis J; Dickson DW
    Acta Neuropathol; 2016 Jan; 131(1):27-48. PubMed ID: 26576562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic heparinoid blocks Tau aggregate cell uptake and amplification.
    Stopschinski BE; Thomas TL; Nadji S; Darvish E; Fan L; Holmes BB; Modi AR; Finnell JG; Kashmer OM; Estill-Terpack S; Mirbaha H; Luu HS; Diamond MI
    J Biol Chem; 2020 Mar; 295(10):2974-2983. PubMed ID: 31974166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.
    Narasimhan S; Guo JL; Changolkar L; Stieber A; McBride JD; Silva LV; He Z; Zhang B; Gathagan RJ; Trojanowski JQ; Lee VMY
    J Neurosci; 2017 Nov; 37(47):11406-11423. PubMed ID: 29054878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.